Global Fund Approves US$9.2 Billion in New Grants to Accelerate Fight Against HIV, TB and Malaria in More than 70 Countries

The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants starting in 2024. 152 new grants will begin implementation this month, supporting more than 70 countries to continue their lifesaving work to end the three epidemics and build sustainable and climate-resilient systems for health over the 2024-2026 period.

In November 2022, following a record-breaking Seventh Replenishment outcome of US$15.7 billion, the Board of the Global Fund approved the largest-ever investments to boost the fight against HIV, TB and malaria and strengthen health systems: US$13.7 billion, including US$13.1 billion in country allocations, to more than 120 countries over the 2024-2026 period.

The remaining country allocation funds to invest over the next 3 years – up to US$4 billion – are scheduled for later start dates.

Peter Sands, Executive Director of the Global Fund, said: “Sustaining our progress against the world’s deadliest diseases and helping build more resilient and inclusive systems for health will save millions of lives, address glaring health inequities and enable communities to flourish. At a time when so many of the poorest and most vulnerable people are also being affected by climate change, conflict, economic stresses and an erosion of human rights, there is an imperative to ensure sustained and adequate funding of such demonstrably effective lifesaving interventions. We are extremely thankful to our donors for their continued support and to all our stakeholders across the partnership who have worked so hard to develop these new grants so quickly and effectively.”

Over the past year, country partners have worked with Country Coordinating Mechanisms (national government, community and health experts that develop and guide Global Fund-supported programs in a country) to develop detailed funding requests for programs to respond to the epidemics at the country level. As part of the Global Fund’s grant-making process, all funding requests are reviewed by an independent Technical Review Panel and then by the Grant Approvals Committee for quality and comprehensiveness before going to the Global Fund Board for final approval. Once the Board approves a grant, the Grant Confirmation is signed, and the Global Fund can process the first disbursement.

In addition to the core grants awarded, the Global Fund continues supporting countries to reinvest funds from the COVID-19 Response Mechanism (C19RM) in health systems strengthening and pandemic preparedness. This includes over US$2 billion in investments for medical oxygen, community systems and community health workers, supply chain, laboratories, surveillance, data systems and inter-operability, and waste management.

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.